The case for preventive prostatectomy in patients with a high risk of malignancy
Michał C. Czarnogórski, Wojciech Tomczak, Krzysztof Koper, Wojciech Krajewski, Tomasz Drewa, Jan Adamowicz Nature Reviews Urology
· Springer Nature
· 2026-11-18
· DOI: 10.1038/s41585-026-01213-z
Abstract
Nature Reviews Urology, Published online: 18 November 2026; doi:10.1038/s41585-026-01213-z Growing recognition of hereditary prostate cancer risk has prompted the consideration of preventive surgical approaches. In this Perspective, the authors discuss whether risk-eliminating, function-sparing prostatectomy could become a viable strategy for carefully selected high-risk individuals, examining the evidence, controversies and future research needed to guide clinical implementation.
Michał C. Czarnogórski, Wojciech Tomczak, Krzysztof Koper, Wojciech Krajewski, Tomasz Drewa, Jan Adamowicz. The case for preventive prostatectomy in patients with a high risk of malignancy. // Nature Reviews Urology. – 2026. – DOI: 10.1038/s41585-026-01213-z. – URL: https://www.nature.com/articles/s41585-026-01213-z
Michał C. Czarnogórski, Wojciech Tomczak, Krzysztof Koper, Wojciech Krajewski, Tomasz Drewa, & Jan Adamowicz (2026). The case for preventive prostatectomy in patients with a high risk of malignancy. Nature Reviews Urology. https://doi.org/10.1038/s41585-026-01213-z
Michał C. Czarnogórski, et al. “The case for preventive prostatectomy in patients with a high risk of malignancy.” Nature Reviews Urology, 2026. doi:10.1038/s41585-026-01213-z.
@article{Czarnogrski2026,
title = {The case for preventive prostatectomy in patients with a high risk of malignancy},
author = {Czarnogórski, Michał C. and Tomczak, Wojciech and Koper, Krzysztof and Krajewski, Wojciech and Drewa, Tomasz and Adamowicz, Jan},
journal = {Nature Reviews Urology},
year = {2026},
doi = {10.1038/s41585-026-01213-z},
url = {https://www.nature.com/articles/s41585-026-01213-z}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...